¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Glycogen Phosphorylase, Liver Form"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • open chain form
    ¿­¸°»ç½½Çü
  • pre-erythrocytic form
    ÀüÀûÇ÷±¸Çü
  • parasitic form
    ±â»ýÇü
  • ring-form
    ¹ÝÁöÇü, À±»óü
  • biliary cirrhotic liver
    ¾µ°³°ü°æÈ­°£, ´ã°ü°æÈ­°£
  • cod-liver oil
    °£À¯
  • hobnail liver
    ¡¸ð¾ç°£
  • iron liver
    °£Ã¶Áõ
  • liver
    °£
  • liver acinus
    °£»ù²Ê¸®, °£¼¼¿±
  • liver bile
    °£¾µ°³Áó, °£´ãÁó
  • liver cancer
    °£¾Ï
  • liver cirrhosis
    °£°æÈ­Áõ
  • liver disease
    °£Áúȯ, °£º´
  • liver distomiasis
    °£ÈíÃæÁõ, °£µð½ºÅ丶Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mycelial form
    ±Õ»çÇü
  • open chain form
    ¿­¸°»ç½½Çü
  • parasitic form
    ±â»ýÇü
  • pre-erythrocytic form
    ÀüÀûÇ÷±¸Çü
  • ring-form
    ¹ÝÁöÇü, À±»óü
  • liver acinus
    °£»ù²Ê¸®
  • biliary cirrhotic liver
    ´ãµµ¼º°æº¯°£, ¾µ°³°ü°æÈ­°£
  • liver bile
    °£´ãÁó
  • cystic liver
    ³¶¼º°£, ¹°È¤°£
  • obstructive liver cirrhosis
    ÆÐ¼â°£°æÈ­(Áõ)
  • toxic liver cirrhosis
    µ¶¼º°£°æÈ­(Áõ)
  • liver disease
    °£º´, °£Áúȯ
  • liver distomiasis
    °£ÈíÃæÁõ
  • liver fluke
    °£ÈíÃæ
  • iron liver
    °£Ã¶Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • Glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø(ÓØê«)
  • Glycogen synthase
    ±Û¸®ÄÚ°ÕÇÕ¼º(ùêà÷)
  • Glycogen-lactic acid system
    ±Û¸®ÄÚ°Õ-¶ôÆ®»ê°è
  • anterior segment of liver
    ¾Õ±¸¿ª
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø
  • glycogen
    ±Û¶óÀÌÄÚÀü, ´ç¿ø.
  • glycogen
    ±Û¸®ÄÚ°Õ, ´ç¿ø.
  • glycogen
    ´ç¿ø, ±Û¸®ÄÚ¿À°Õ
  • glycogen degeneration
    ±Û¸®ÄÚ°Õº¯¼º(¡­Ü¨àõ).
  • glycogen granule
    ±Û¸®ÄÚ°Õ°ú¸³
  • glycogen granule
    ´ç¿ø°ú¸³
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glycogen granule
    ´ç¿ø°ú¸³
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
  • glycogen storage disease
    ´ç¿ø ÃàÀûÁúȯ(ÓØê«õëîÝòðü´)
  • glycogen synthase
    ´ç¿ø ÇÕ¼ºÈ¿¼Ò
  • granule, glycogen
    ±Û¸®ÄÚ°Õ°ú¸³
  • hepatic glycogen
    °£(ÊÜ)±Û¸®ÄÚ°Õ.
  • kidney,glycogen vacuolation
    ±Û¸®ÄÚ°Õ°øÆ÷È­(¡­Íöøàûù)
  • labile glycogen
    ºÒ¾ÈÁ¤±Û¸®ÄÚ°Õ.
  • type II glycogen storage disease
    ´ç¿øÀúÀ庴IIÇü(ÓØê«îÍíúÜ»ì£úþ).
  • alveolar ridge running in concave form
    ¿ä¸¸ÇüÄ¡Á¶¿¬(èêØ¶úþöÍðËæÞ).
  • auxiliary retention form
    º¸Á¶Àû À¯ÁöÇüÅÂ(ÜÍð¾îÜë«ò¥û¡÷¾) õµ¿(ó¸÷Ó)ÀÇ .
  • balanced form
    ±ÕÇüÇü(гû¬û¡).
  • band form =stab cell
    °£»óÈ£Áß±¸
  • bell form
    Á¾Çü(̴̡).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • starch phosphorylase
    ³ì¸» Æ÷½ºÆ÷¸±·¹À̽º
  • synthase-phosphorylase kinase
    ½ÅÅ×À̽º-Æ÷½ºÆ÷¸±·¹À̽º Ä«À̳×À̽º
  • activated form
    Ȱ¼ºÈ­Çü (üÀàõûùû¡)
  • active form
    Ȱ¼ºÇü(üÀàõû¡)
  • A form
    A Çü(úþ)
  • A form particle
    A ÇüÀÔÀÚ(úþí£í­)
  • B form
    BÇü(úþ)
  • C form
    CÇü(úþ)
  • D-form
    "DÇü(û¡), (å²) dependent form"
  • I form
    I Çü(úþ)
  • independent form
    µ¶¸³Çü(Լءúþ)
  • lariat form
    ·¡¸®¾ù Çü(úþ)
  • L-form
    LÇü(úþ)
  • replicating form
    º¹Á¦ Çü(úþ)
  • replicative form
    º¹Á¦ Çü(úþ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MLG mesiolingual groove; mitochondrial lipid glycogen
ALF acute liver failure; American Liver Foundation; assisted living facilities
FLC family life cycle; fatty liver cell; fetal liver cell; Friend leukemia cell
PFKL phosphofructokinase, liver type; 6-phosphofructo-2-kinase, liver type
NP Nucleoside Phosphorylase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GSK3 Glycogen Synthase Kinase 3
GSD 1a Glycogen storage disease type 1a
GSD I Glycogen storage diseases type I
GSD III Glycogen storage disease type III
GSD Ia Glycogen storage disease type Ia
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • liver infarction
    °£ °æ»öÁõ
  • liver isozyme fraction
    °£ È¿¼Ò À¯ºÐ
  • liver scan
    °£ ÁÖ»ç
  • percutaneous needle biopsy of liver
    °æÇÇ °£ ħ »ý°Ë
  • wandering liver
    À¯ÁÖ °£, À¯ÁÖ °£Àå
  • abortive form
    ºÎÀüÇü
  • abrupt form
    ±ÞÃßÇü
  • allotropic form
    µ¿¼Òü
  • alveolar ridge running in concave form
    ¿ä¸¸Çü Ä¡Á¶¿¬
  • anatomic form
    ÇØºÎÇÐÀû ÇüÅÂ
  • anterior tooth form
    ÀüÄ¡ºÎ Ä¡Çü
  • atrophic form
    À§Ãà ÇüÅÂ
  • auxiliary retention form
    º¸Á¶Àû À¯Áö ÇüÅÂ
  • balanced form
    ±ÕÇüÇü
  • band form
    ´ë»óü, °£»ó, °£»ó ¼¼Æ÷, ´ë»óÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
glycogen synthase <enzyme> An enzyme of the transferase class that catalyses the reaction of udpglucose and (1,4-alpha-d-glucosyl)n to yield udp and 1,4-alpha-d-glucosyl)n+1. The reaction is highly regulated by allosteric effectors, by phosphorylation reactions, and by insulin.
Chemical name: UDPglucose:glycogen 4-alpha-D-glucosyltransferase
Registry number: EC 2.4.1.11
(12 Dec 1998)
glycogen synthase-d phosphatase <enzyme> An enzyme that catalyses the conversion of phosphorylated, inactive glycogen synthase d to active dephosphoglycogen synthase I.
Chemical name: (UDPglucose:glycogen 4-alpha-D-glucosyltransferase-D) phosphohydrolase
Registry number: EC 3.1.3.42
(12 Dec 1998)
glycogen synthetase <enzyme> An enzyme which makes amylose out of glucose molecules (a type of sugar) and attaches them to glycogen (a type of polysaccharide).
(09 Oct 1997)
UDPglucose-glycogen glucose 1-phosphotransferase <enzyme> Catalyses the transfer of glucose 1-phosphate onto c-6 of glucose residues in glycogen to form a phosphodiester
Registry number: EC 2.7.8.-
Synonym: ugg-glcptase
(26 Jun 1999)
a-form DNA <molecular biology> One of several forms that can be assumed by a double helix. A-DNA is stable in dehydrated conditions.
This form is less common than the dominant form found under physiological conditions -- beta-DNA. This form is also assumed by DNA-RNA hybrid helices and by regions of double-stranded RNA. It is a right-handed helix and is a more compact form than beta-DNA.
(09 Oct 1997)
alpha,alpha-trehalose phosphorylase <enzyme> Chemical name: alpha-d-glucopyranosyl-alpha-d-glucopyranose orthophosphate glucosyltransferase
Registry number: EC 2.4.1.64
Synonym: trehalose phosphorylase
(26 Jun 1999)
alpha-glucan phosphorylase <enzyme> Enzyme that catalyses the sequential removal of glycosyl residues from glycogen to yield one glucose-1-phosphate per reaction. Its activity is controlled by phosphorylation (by phosphorylase kinase).
(21 Jun 2000)
boat form The less stable of two conformations assumed by 6-membered cyclic sugars (pyranoses) or cyclohexane derivatives, as opposed to chair form.
See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
maltodextrin phosphorylase <enzyme> From E coli
Registry number: EC 2.4.1.-
Synonym: e350a
(26 Jun 1999)
GDPmannose phosphorylase <enzyme> A transferase that catalyses the transfer of GDP to the mannose of mannose-1-phosphate.
Consider also the bifunctional enzyme, phosphomannose isomerase-guanosine diphospho-d-mannose pyrophosphorylase; rfbm has similarity to long-chain, iron-containing alcohol dehydrogenases
Registry number: EC 2.7.7.13
Synonym: GDPmannose phosphorylase, GDP mannose pyrophosphorylase, GTP-alpha-d-mannose-1-phosphate guanylyltransferase, GDP-mannose pyrophosphorylase, rfbm gene product, rfbm protein
(26 Jun 1999)
cavity preparation form The configuration or shape of a cavity preparation.
(05 Mar 2000)
cellodextrin phosphorylase <enzyme> Reverse reaction is used to synthesise cellodextrins
Registry number: EC 2.4.1.49
(26 Jun 1999)
replicative form An intermediate stage in the replication of either DNA or RNA viral genomes that is usually double stranded, the altered, double-stranded form to which single-stranded coliphage DNA is converted after infection of a susceptible bacterium, formation of the complementary ("minus") strand being mediated by enzymes that were present in the bacterium before entrance of the viral ("plus") strand.
(05 Mar 2000)
resistance form The shape given to a cavity preparation that enables the dental restoration to withstand masticatory forces.
(05 Mar 2000)
retention form The shape of a cavity preparation that prevents displacement of the dental restoration by lateral or tipping forces as well as masticatory forces.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dress form
    (¾çÀç¿ë)ÀÎü ¸ðÇü
  • form
    ¸ð¾ç;¿ÜÇü;¸ð½À;¸ö¸Å;Çü½Ä;¹æ½Ä;Çü;Çü¼ºµÇ´Ù;»ý±â´Ù;´ëÇüÀ̵ǴÙ;Çü¼ºÇÏ´Ù;Çüü¸¦ ÀÌ·ç´Ù;´Ü·ÃÇÏ´Ù. formable a.
  • form board
    (ÄÜÅ©¸®Æ® °ø»çÀÇ) ÇüƲ
  • form class
    ÇüÅ·ù(ÇüÅÂÀû Ư¡À» °øÀ¯ÇÏ´Â ¾î±º µî)
  • form criticism
    ¾ç½Ä ºñÆòÇÐ
  • form frag
    (À¯Ã¼ ¼ÓÀ» ¿îµ¿ÇÏ´Â ¹°Ã¼ÀÇ) Çü»ó Ç×·Â
  • form genus
    ÇüżÓ
  • form letter
    °°Àº ±ÛÀÇ ÆíÁö(Àμâ,º¹»çµÈ)
  • form master
    ÇÐ±Þ ´ãÀÓ ±³»ç
  • form sheet
    (°æ¸¶ÀÇ) ¿¹»óÁö;(Èĺ¸ÀÚ,°æ±âÀÚ¿¡ °üÇÑ) »ó¼¼ÇÑ ±â·Ï
  • form word
    =FUNCTON WORD
  • free form
    ÀÚÀ¯Çü½Ä
  • inner speech form
    ³»ºÎ ¾ð¾î Çü½Ä
  • progressive form
    ÁøÇàÇü
  • racing form
    °æ¸¶ ½Å¹®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á